Solid Biosciences
SLDB
62 hedge funds and large institutions have $53.2M invested in Solid Biosciences in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 11 closing their positions.
200% more call options, than puts
Call options by funds: $9K | Put options by funds: $3K
0.14% less ownership
Funds ownership: 3.88% → 3.73% (-0.14%)
6% less funds holding
Funds holding: 66 → 62 (-4)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
33% less capital invested
Capital invested by funds: $79.1M → $53.2M (-$25.9M)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$208K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$204K |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$173K |
| 4 |
Millennium Management
New York
|
+$167K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$166K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.11M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$269K |
| 3 |
EP
Eversept Partners
New York
|
-$255K |
| 4 |
AG
Artal Group
Luxembourg
|
-$230K |
| 5 |
JP Morgan Chase
New York
|
-$202K |
SLDB Hedge Fund Activity: Q3 2020 in Review
62 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q3 2020, worth a combined $53.2M — down 33% from $79.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of SLDB and 7 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 17 added.
The largest buyer was Bank of America, adding an estimated $208K. The largest seller was Morgan Stanley, cutting an estimated $1.11M.
- 62 institutional investors held Solid Biosciences (SLDB) as of Q3 2020, down from 66 in Q2 2020.
- Funds reported $53.2M of Solid Biosciences stock for Q3 2020, down 33% quarter-over-quarter.
- 7 funds opened new Solid Biosciences positions in Q3 2020 and 11 closed out, a net change of -4 holders.
- The largest Solid Biosciences buyer in Q3 2020 was Bank of America, an estimated $208K added.
- The largest Solid Biosciences seller in Q3 2020 was Morgan Stanley, an estimated $1.11M sold.
Based on aggregated 13F filings for Q3 2020.